Key terms

About FEMY

Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest FEMY news

Apr 18 8:37am ET Femasys CEO meets with members of Congress to raise awareness Apr 02 3:45pm ET Femasys: A Buy Rating on Innovative Reproductive Solutions and Market Expansion Potential Apr 01 6:05am ET Femasys price target raised to $12 from $10 at H.C. Wainwright Mar 21 2:30pm ET Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC) Mar 21 12:45pm ET Femasys participates in a conference call with JonesResearch Mar 21 11:08am ET Femasys participates in a conference call with JonesResearch Mar 21 6:31am ET Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX) Mar 20 8:16am ET Femasys announces topline data from trial of FemaSeed for infertility Mar 06 9:04am ET Femasys completes the first in-office commercial procedure with FemaSeed Feb 28 9:32am ET Femasys Reveals Corporate Update and FDA-Cleared Infertility Solution Feb 28 9:03am ET Femasys’ FemaSeed to serve as first-line therapeutic option Feb 23 9:04am ET Alabama decision could spur interest in Femasys, says JonesResearch Feb 07 4:18am ET Femasys Welcomes New Chief Commercial Officer Mr. Spector Feb 06 8:50am ET Femasys appoints Spector as CCO Jan 26 8:09am ET Femasys begins enrollment for FemBloc trial Jan 23 8:33am ET Femasys begins FemBloc trial enrollment at University of Utah

No recent press releases are available for FEMY

FEMY Financials

1-year income & revenue

Key terms

FEMY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

FEMY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms